BIOGEN INC

CAMBRIDGE, MA How do I update this listing?

Create Email Alert

Biogen is based out of Cambridge. Biogen Inc.'s principal activity is to develop, manufacture and market novel human therapeutic products. The Group currently sells AVONEX (r) for the treatment of relapsing multiple sclerosis (MS) and commencing in 2003, AMEVIVE (r) for the treatment of adult patients with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy. It also has a significant number of ongoing research programs. The products of the Group are marketed in the United States, Europe, Asia and other foreign countries. Vaccines and diagnostic products accounted for 90% of 2002 revenues and Royalties, 10%. The firm has no submitted 13F filings and does not appear to be an investment advisor.

Contact Info

biogen inc
14 CAMBRIDGE CTR
CAMBRIDGE MA    02142

Business Phone: 6176792000
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Elevate your investments